BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 35191116)

  • 1. Clinical exome sequencing-Mistakes and caveats.
    Corominas J; Smeekens SP; Nelen MR; Yntema HG; Kamsteeg EJ; Pfundt R; Gilissen C
    Hum Mutat; 2022 Aug; 43(8):1041-1055. PubMed ID: 35191116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunities and challenges of whole-genome and -exome sequencing.
    Petersen BS; Fredrich B; Hoeppner MP; Ellinghaus D; Franke A
    BMC Genet; 2017 Feb; 18(1):14. PubMed ID: 28193154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of Exome Sequencing to Identify Rare Genetic Diseases.
    Udupa P; Ghosh DK
    Methods Mol Biol; 2024; 2719():79-98. PubMed ID: 37803113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis and annotation of whole-genome or whole-exome sequencing-derived variants for clinical diagnosis.
    Worthey EA
    Curr Protoc Hum Genet; 2013 Oct; 79():9.24.1-9.24.24. PubMed ID: 24510652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease.
    Hegde M; Santani A; Mao R; Ferreira-Gonzalez A; Weck KE; Voelkerding KV
    Arch Pathol Lab Med; 2017 Jun; 141(6):798-805. PubMed ID: 28362156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel bioinformatic developments for exome sequencing.
    Lelieveld SH; Veltman JA; Gilissen C
    Hum Genet; 2016 Jun; 135(6):603-14. PubMed ID: 27075447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical guide to filtering and prioritizing genetic variants.
    Jalali Sefid Dashti M; Gamieldien J
    Biotechniques; 2017 Jan; 62(1):18-30. PubMed ID: 28118812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance comparison: exome sequencing as a single test replacing Sanger sequencing.
    Fridman H; Bormans C; Einhorn M; Au D; Bormans A; Porat Y; Sanchez LF; Manning B; Levy-Lahad E; Behar DM
    Mol Genet Genomics; 2021 May; 296(3):653-663. PubMed ID: 33694043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translating exome sequencing from research to clinical diagnostics.
    Coonrod EM; Margraf RL; Voelkerding KV
    Clin Chem Lab Med; 2011 Dec; 50(7):1161-8. PubMed ID: 22850020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an evidence-based algorithm that optimizes sensitivity and specificity in ES-based diagnostics of a clinically heterogeneous patient population.
    Bauer P; Kandaswamy KK; Weiss MER; Paknia O; Werber M; Bertoli-Avella AM; Yüksel Z; Bochinska M; Oprea GE; Kishore S; Weckesser V; Karges E; Rolfs A
    Genet Med; 2019 Jan; 21(1):53-61. PubMed ID: 30100613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome-wide benchmark of difficult-to-sequence regions using short-read next-generation DNA sequencing.
    Hijikata A; Suyama M; Kikugawa S; Matoba R; Naruto T; Enomoto Y; Kurosawa K; Harada N; Yanagi K; Kaname T; Miyako K; Takazawa M; Sasai H; Hosokawa J; Itoga S; Yamaguchi T; Kosho T; Matsubara K; Kuroki Y; Fukami M; Adachi K; Nanba E; Tsuchida N; Uchiyama Y; Matsumoto N; Nishimura K; Ohara O
    Nucleic Acids Res; 2024 Jan; 52(1):114-124. PubMed ID: 38015437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of genetic disorders in childhood with next-generation sequencing].
    Menyhárt O; Győrffy B; Szabó A
    Orv Hetil; 2022 Dec; 163(51):2027-2040. PubMed ID: 36528826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.
    Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M
    Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lake Louise mutation detection meeting 2013: clinical translation of next-generation sequencing requires optimization of workflows and interpretation of variants.
    Smith A; Boycott KM; Jarinova O
    Hum Mutat; 2014 Feb; 35(2):265-9. PubMed ID: 24282140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing rare diseases after the exome.
    Frésard L; Montgomery SB
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30559314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulating whole exome sequencing as a diagnostic test.
    Lapin V; Mighion LC; da Silva CP; Cuperus Y; Bean LJ; Hegde MR
    Hum Genet; 2016 Jun; 135(6):655-73. PubMed ID: 27167135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted next-generation sequencing panels for monogenetic disorders in clinical diagnostics: the opportunities and challenges.
    de Koning TJ; Jongbloed JD; Sikkema-Raddatz B; Sinke RJ
    Expert Rev Mol Diagn; 2015 Jan; 15(1):61-70. PubMed ID: 25367078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus Genotyper for Exome Sequencing (CGES): improving the quality of exome variant genotypes.
    Trubetskoy V; Rodriguez A; Dave U; Campbell N; Crawford EL; Cook EH; Sutcliffe JS; Foster I; Madduri R; Cox NJ; Davis LK
    Bioinformatics; 2015 Jan; 31(2):187-93. PubMed ID: 25270638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of next-generation sequencing for Mendelian diseases.
    Jamuar SS; Tan EC
    Hum Genomics; 2015 Jun; 9(1):10. PubMed ID: 26076878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
    LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
    PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.